Home » Topics » Articles » Insight

Insight
RSS

Companies Continue To Refine Approaches To Antisense

June 14, 1999

Clinical Trials Update: May 1999

June 14, 1999

Public Financing Of Biotechnology: May 1999

June 7, 1999

Money Raised By Biotech In 1999: January May

June 7, 1999

Financing Outlook Brighter; Small-Caps Catch Up Slowly

June 7, 1999

Other Financings Of Public Biotechnology Companies: May 1999

June 7, 1999

Market Capitalization Of Selected Canadian Biotechnology Firms

May 31, 1999

Canada's Biotech Sector Marches Toward Maturity

May 31, 1999

Status Of Selected Products In Development At Canadian Biotechnology Firms

May 31, 1999

FDA Takes Steps To Speed Drug Development Process

May 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...